These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12657271)

  • 1. Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Zhang Z
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1313-6. PubMed ID: 12657271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.
    Fensome A; Koko M; Wrobel J; Zhang P; Zhang Z; Cohen J; Lundeen S; Rudnick K; Zhu Y; Winneker R
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1317-20. PubMed ID: 12657272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Lundeen S; Marschke KB; Zhang Z
    J Med Chem; 2002 Sep; 45(20):4379-82. PubMed ID: 12238914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.
    Zhang P; Terefenko EA; Fensome A; Zhang Z; Zhu Y; Cohen J; Winneker R; Wrobel J; Yardley J
    Bioorg Med Chem Lett; 2002 Mar; 12(5):787-90. PubMed ID: 11859003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.
    Zhou HB; Lee JH; Mayne CG; Carlson KE; Katzenellenbogen JA
    J Med Chem; 2010 Apr; 53(8):3349-60. PubMed ID: 20355713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.
    Higuchi RI; Thompson AW; Chen JH; Caferro TR; Cummings ML; Deckhut CP; Adams ME; Tegley CM; Edwards JP; López FJ; Kallel EA; Karanewsky DS; Schrader WT; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5442-6. PubMed ID: 17703938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
    J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
    Pridjian G; Schmit V; Schreiber J
    J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and pharmacological properties of a potent and selective novel nonsteroidal progesterone receptor agonist tanaproget.
    Zhang Z; Olland AM; Zhu Y; Cohen J; Berrodin T; Chippari S; Appavu C; Li S; Wilhem J; Chopra R; Fensome A; Zhang P; Wrobel J; Unwalla RJ; Lyttle CR; Winneker RC
    J Biol Chem; 2005 Aug; 280(31):28468-75. PubMed ID: 15937332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
    Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.
    Kang FA; Allan G; Guan J; Jain N; Linton O; Tannenbaum P; Xu J; Zhu P; Gunnet J; Chen X; Demarest K; Lundeen S; Sui Z
    Bioorg Med Chem Lett; 2007 Feb; 17(4):907-10. PubMed ID: 17169557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
    Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
    Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.
    Zhang Z; Lundeen SG; Slayden O; Zhu Y; Cohen J; Berrodin TJ; Bretz J; Chippari S; Wrobel J; Zhang P; Fensome A; Winneker RC; Yudt MR
    Ernst Schering Found Symp Proc; 2007; (1):171-97. PubMed ID: 18540573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.
    Ghatge RP; Jacobsen BM; Schittone SA; Horwitz KB
    Breast Cancer Res; 2005; 7(6):R1036-50. PubMed ID: 16457685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators.
    Zhi L; Tegley CM; Pio B; Edwards JP; Motamedi M; Jones TK; Marschke KB; Mais DE; Risek B; Schrader WT
    J Med Chem; 2003 Sep; 46(19):4104-12. PubMed ID: 12954062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.